Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.
Reuters NewMedia - Monday, November 22, 1999
Cel-Sci said that its HGP-30W preventive HIV vaccine for HIV-1 subtype C induced both cellular, or T-cell, and humoral, or antibody, immune responses in the study.
The company said it intends to present the final results at an "appropriate" HIV/AIDS conference and/or publish them in a peer-reviewed scientific journal. Cel-Sci noted that subtype B is the prevalent subtype in the U.S. and Western Europe, and several HIV-1 vaccines have been tested or are currently being tested in the developing world for that subtype.
The company said that it has no knowledge that there are other HIV vaccines in human studies directed against subtype C.
It noted that earlier this year, the World Bank announced that it was planning to set up a $5 billion fund to help developing countries purchase those HIV vaccines proven to be effective.
991122
RE991109
Copyright © 1999 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .